Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Angiotensin II type-1 receptor (AT1) is a G protein-coupled receptor (GPCR) that mediates most of the known physiological and pathophysiological effects of angiotensin II. It plays a crucial role in cardiovascular regulation, blood pressure control, and fluid homeostasis. It is a primary therapeutic target for hypertension and related cardiovascular diseases. Drugs targeting AT1, such as Angiotensin Receptor Blockers (ARBs), are widely used clinically.
Selective antagonism of the Angiotensin II Type-1 Receptor
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Angiotensin II Type-1 Receptor (AT1).